Loading...
Safilo Group S.p.A.
SAFLY•PNK
Healthcare
Medical - Instruments & Supplies
$2.29
$0.00(0.00%)
Safilo Group S.p.A. (SAFLY) Financial Performance & Income Statement Overview
Review Safilo Group S.p.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-3.08%
↓ 3.08%
Operating Income Growth
529.54%
↑ 529.54%
Net Income Growth
190.45%
↑ 190.45%
Operating Cash Flow Growth
59.74%
↑ 59.74%
Operating Margin
4.28%
↑ 4.28%
Gross Margin
59.68%
↑ 59.68%
Net Profit Margin
2.24%
↑ 2.24%
ROE
5.43%
↑ 5.43%
ROIC
7.53%
↑ 7.53%
Safilo Group S.p.A. (SAFLY) Income Statement & Financial Overview
Review Safilo Group S.p.A.'s (SAFLY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $461.26M | $265.98M | $265.98M | $474.59M |
| Cost of Revenue | $203.10M | $106.39M | $106.39M | $231.61M |
| Gross Profit | $258.16M | $159.59M | $159.59M | $242.98M |
| Gross Profit Ratio | $0.56 | $0.60 | $0.60 | $0.51 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $7.00M |
| SG&A Expenses | $244.69M | $140.79M | $140.79M | $251.56M |
| Operating Expenses | $246.91M | $144.31M | $145.05M | $253.12M |
| Total Costs & Expenses | -$450.007M | $250.69M | $251.43M | $484.73M |
| Interest Income | $863000.00 | $0.00 | $2.16M | $0.00 |
| Interest Expense | $9.45M | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $20.42M | $6.28M | $6.28M | $29.43M |
| EBITDA | $36.83M | $24.71M | $24.71M | $19.69M |
| EBITDA Ratio | $0.08 | $0.09 | $0.09 | $0.04 |
| Operating Income | $11.26M | $15.29M | $18.43M | -$10.14M |
| Operating Income Ratio | $0.02 | $0.06 | $0.07 | -$0.02 |
| Other Income/Expenses (Net) | -$4.30M | -$2.90M | -$2.90M | -$10.15M |
| Income Before Tax | $6.96M | $12.38M | $12.38M | -$20.28M |
| Income Before Tax Ratio | $0.02 | $0.05 | $0.05 | -$0.04 |
| Income Tax Expense | $2.41M | $3.74M | $3.74M | -$3.58M |
| Net Income | $4.69M | $8.80M | $8.80M | -$15.69M |
| Net Income Ratio | $0.01 | $0.03 | $0.03 | -$0.03 |
| EPS | $0.01 | $0.02 | $0.02 | -$0.08 |
| Diluted EPS | $0.01 | $0.02 | $0.02 | -$0.08 |
| Weighted Avg Shares Outstanding | $403.24M | $419.19M | $419.19M | $206.91M |
| Weighted Avg Shares Outstanding (Diluted) | $404.07M | $416.74M | $416.74M | $206.91M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan